RENO, NV--(Marketwire - November 30, 2007) - Smartec Holdings Inc. (OTCBB: SMHN) (the "Company" or "Smartec") is pleased to announce that it has entered into a binding Asset Purchase Agreement dated November 27, 2007 with two private companies in respect to the purchase of a proprietary technology for the generation of monoclonal antibodies against various antigens in consideration for 25,638,400 shares in the common stock of the Company. The acquisition is expected to close on or before January 15, 2008.
